Loading...

Bioventix PLC

BVXP.L•LSE
Healthcare
Biotechnology
£2665.00
£15.00(0.57%)

Bioventix PLC (BVXP.L) Company Profile & Overview

Explore Bioventix PLC’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Bioventix PLC (BVXP.L) Company Profile & Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.

SectorHealthcare
IndustryBiotechnology
CEOPeter John Harrison MA

Contact Information

https://www.bioventix.com
441252728001
27–28 Eastcastle Street, Farnham, W1W 8DH

Company Facts

17 Employees
IPO DateApr 29, 2014
CountryGB
Actively Trading

Frequently Asked Questions

;